A. Evans

1.0k total citations
21 papers, 728 citations indexed

About

A. Evans is a scholar working on Molecular Biology, Neurology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, A. Evans has authored 21 papers receiving a total of 728 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Neurology and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in A. Evans's work include Neuroblastoma Research and Treatments (4 papers), Sodium Intake and Health (2 papers) and Neuroendocrine Tumor Research Advances (2 papers). A. Evans is often cited by papers focused on Neuroblastoma Research and Treatments (4 papers), Sodium Intake and Health (2 papers) and Neuroendocrine Tumor Research Advances (2 papers). A. Evans collaborates with scholars based in United Kingdom, United States and France. A. Evans's co-authors include Ronald L. Chard, Mark A. Israel, Seth M. Steinberg, Jane Chatten, Lee J. Helman, Osama M. El‐Badry, A. Bingham, Dominique Arveiler, E. McCrum and Jayne V. Woodside and has published in prestigious journals such as The Lancet, Journal of Clinical Investigation and Annals of the New York Academy of Sciences.

In The Last Decade

A. Evans

21 papers receiving 679 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Evans United Kingdom 13 200 171 141 108 105 21 728
H. James Nickerson United States 13 195 1.0× 155 0.9× 123 0.9× 74 0.7× 127 1.2× 19 754
Marianne Sadler United States 11 53 0.3× 94 0.5× 109 0.8× 121 1.1× 185 1.8× 12 877
T Y Tai Taiwan 17 63 0.3× 242 1.4× 291 2.1× 40 0.4× 110 1.0× 26 948
Paula Jerrard-Dunne Ireland 13 105 0.5× 72 0.4× 79 0.6× 56 0.5× 116 1.1× 19 1.0k
Elke Magdeleyns Netherlands 18 331 1.7× 125 0.7× 248 1.8× 55 0.5× 165 1.6× 21 2.0k
Simona Fica Romania 16 49 0.2× 115 0.7× 230 1.6× 143 1.3× 120 1.1× 99 796
J R Laporte Spain 13 131 0.7× 187 1.1× 32 0.2× 75 0.7× 42 0.4× 24 924
E.‐M. Tolppanen Finland 15 38 0.2× 108 0.6× 159 1.1× 51 0.5× 108 1.0× 24 758
F. H. Epstein United States 10 59 0.3× 143 0.8× 112 0.8× 58 0.5× 240 2.3× 23 779

Countries citing papers authored by A. Evans

Since Specialization
Citations

This map shows the geographic impact of A. Evans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Evans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Evans more than expected).

Fields of papers citing papers by A. Evans

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Evans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Evans. The network helps show where A. Evans may publish in the future.

Co-authorship network of co-authors of A. Evans

This figure shows the co-authorship network connecting the top 25 collaborators of A. Evans. A scholar is included among the top collaborators of A. Evans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Evans. A. Evans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ruidavets, J. B., G. Luc, Annelise Genoux, et al.. (2011). Effects of insulin-like growth factor 1 in preventing acute coronary syndromes: The PRIME study. Atherosclerosis. 218(2). 464–469. 42 indexed citations
2.
Yarnell, J. W. G., CC Patterson, Dominique Arveiler, et al.. (2011). Contribution of lifetime smoking habit in France and Northern Ireland to country and socioeconomic differentials in mortality and cardiovascular incidence: the PRIME Study. Journal of Epidemiology & Community Health. 66(7). 599–604. 3 indexed citations
3.
Stanisławska‐Sachadyn, Anna, Jayne V. Woodside, Carly M. Sayers, et al.. (2010). The transcobalamin (TCN2) 776C>G polymorphism affects homocysteine concentrations among subjects with low vitamin B12 status. European Journal of Clinical Nutrition. 64(11). 1338–1343. 29 indexed citations
4.
Evans, A.. (2008). ET Craig: proto-socialist, phrenologist and public health engineer. International Journal of Epidemiology. 37(3). 490–505. 2 indexed citations
5.
Evans, A.. (2007). Commentary: Sibling trials in Banbridge, County Down. International Journal of Epidemiology. 37(1). 42–45. 2 indexed citations
6.
Evans, A.. (2004). MORGAM (an international pooling of cardiovascular cohorts). International Journal of Epidemiology. 34(1). 21–27. 76 indexed citations
7.
Yarnell, John, Shasha Yu, E. McCrum, et al.. (2004). Education, socioeconomic and lifestyle factors, and risk of coronary heart disease: the PRIME Study. International Journal of Epidemiology. 34(2). 268–275. 88 indexed citations
8.
Marques‐Vidal, Pedro, Barbara Haas, A. Bingham, et al.. (2000). Association of hypertensive status and its drug treatment with lipid and haemostatic factors in middle-aged men: the PRIME Study. Journal of Human Hypertension. 14(8). 511–518. 12 indexed citations
9.
Murray, Liam, et al.. (2000). Season and Outdoor Ambient Temperature. Obstetrics and Gynecology. 96(5, Part 1). 689–695. 5 indexed citations
10.
Evans, A., J. B. Ruidavets, E. McCrum, et al.. (1995). Autres pays, autres coeurs? Dietary patterns, risk factors and ischaemic heart disease in Belfast and Toulouse. QJM. 88(7). 469–77. 57 indexed citations
11.
Visvikis‐Siest, Sophie, Jean‐Pierre Cambou, Dominique Arveiler, et al.. (1993). Apolipoprotein B signal peptide polymorphism in patients with myocardial infarction and controls. Human Genetics. 90(5). 561–5. 36 indexed citations
12.
Cooper, Mark J., Seth M. Steinberg, Jane Chatten, A. Evans, & Mark A. Israel. (1992). Plasticity of neuroblastoma tumor cells to differentiate along a fetal adrenal ganglionic lineage predicts for improved patient survival.. Journal of Clinical Investigation. 90(6). 2402–2408. 25 indexed citations
13.
El‐Badry, Osama M., Lee J. Helman, Jane Chatten, et al.. (1991). Insulin-like growth factor II-mediated proliferation of human neuroblastoma.. Journal of Clinical Investigation. 87(2). 648–657. 114 indexed citations
14.
Smith, W. C., et al.. (1989). BLOOD CHOLESTEROL: IS POPULATION SCREENING WARRANTED IN THE UK?. The Lancet. 333(8634). 372–373. 21 indexed citations
15.
Chance, B., Elizabeth T. Borer, A. Evans, et al.. (1988). Optical and Nuclear Magnetic Resonance Studies of Hypoxia in Human Tissue and Tumors a. Annals of the New York Academy of Sciences. 551(1). 1–16. 33 indexed citations
16.
Raney, Beverly, A. Evans, Linda Granowetter, et al.. (1988). Nonsurgical Management of Children With Recurrent OT Unresectable Fibromatosis. The Journal of Urology. 139(4). 881–881. 6 indexed citations
17.
Cooper, Mark J., et al.. (1988). Chromogranin A expression in childhood peripheral neuroectodermal tumors.. PubMed. 271. 175–84. 7 indexed citations
18.
Evans, A., et al.. (1981). Do infants with stage IV-S neuroblastoma need treatment?. Archives of Disease in Childhood. 56(4). 271–274. 114 indexed citations
19.
Evans, A.. (1976). Janeway Lecture: Pediatric cancer treatment: a model for oncology. American Journal of Roentgenology. 127(6). 891–895. 1 indexed citations
20.
Leikin, Sanford, Irwin D. Bernstein, A. Evans, et al.. (1976). Use of combination adriamycin (NSC-123127) and DTIC (NSC-45388) in children with advanced stage IV neuroblastoma.. PubMed. 59(5). 1015–8. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026